HC Scientific is described in the article as a Chinese life sciences firm. The company has secured 300 million yuan (about $41.2 million) in an extended Series B financing. The extension was reported as co-led by Lake Bleu Capital. Lake Bleu Capital is identified as a Hong Kong–based investor that specialises in healthcare investing primarily in the Greater China region. The article does not disclose HC Scientific’s specific core products, future plans, or operating metrics. No additional financial or operational details were provided in the article.

Total raised

$41M

Funding rounds

1

Latest round

Series B

Latest activity

Aug 2023